Actavis plc - see footnote investment history in Columbia laboratories inc

Filed on 2014-03-12 by Actavis Plc SEC CIK 1578845 Form 4/a

Accession 0001179110-14-005102.txt Sec File: edgar/data/1578845/0001179110-14-005102-index.htm

2014-03-07 Actavis Plc (CIK 1578845) through See Footnote

Invested in Columbia Laboratories Inc sold 1400000 shares at $6.0779 remaining shares owned 0

Common Stock Columbia Laboratories Inc Cbrx Transaction code: S Open market or private sale of securities

f1 the shares reported herein reflect the 1-for-8 reverse stock split of the issuer's common stock which took effect on august 9, 2013.
f3 this amendment to form 4 is being filed solely to correct the price per share amount in column 4 from $5.76 to $6.0779.
f2 coventry acquisition llc, the direct record holder of the shares reported herein, is an indirect subsidiary of actavis plc.


Filed on 2014-03-11 by Actavis Plc SEC CIK 1578845 Form 4

Accession 0001179110-14-004981.txt Sec File: edgar/data/1578845/0001179110-14-004981-index.htm

2014-03-07 Actavis Plc (CIK 1578845) through See Footnote

Invested in Columbia Laboratories Inc sold 1400000 shares at $5.76 remaining shares owned 0

Common Stock Columbia Laboratories Inc Cbrx Transaction code: S Open market or private sale of securities

f1 the shares reported herein reflect the 1-for-8 reverse stock split of the issuer's common stock which took effect on august 9, 2013.
f2 coventry acquisition llc, the direct record holder of the shares reported herein, is an indirect subsidiary of actavis plc.